Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2850388
Reference Type
Journal Article
Title
Endocrine disruption effects of long-term exposure to perfluorodecanoic acid (PFDA) and perfluorotridecanoic acid (PFTrDA) in zebrafish (Danio rerio) and related mechanisms
Author(s)
Jo, A; Ji, K; Choi, K;
Year
2014
Is Peer Reviewed?
Yes
Journal
Chemosphere
ISSN:
0045-6535
EISSN:
1879-1298
Volume
108
Page Numbers
360-366
Language
English
PMID
24582365
DOI
10.1016/j.chemosphere.2014.01.080
Web of Science Id
WOS:000337881600047
URL
http://
://WOS:000337881600047
Exit
Relationship(s)
is supplemented by
3981269
: Supporting information
Abstract
Perfluoroalkyl acids (PFAAs) have been frequently detected in both the environment and biota, however the endocrine disruption potentials and underlying mechanism of long-chain PFAAs have not yet been fully understood in fish. In the present study, the effects of perfluorodecanoic acid (PFDA) and perfluorotridecanoic acid (PFTrDA) on sex steroid hormones and expression of mRNA of selected genes in hypothalamic-pituitary-gonad (HPG) axis were evaluated after 120 d exposure of zebrafish. In addition, production of sex hormones and transcription of steroidogenic genes were measured after in vitro exposure of H295R cells for 48 h. Exposure to PFTrDA resulted in reduced production of testosterone (T) along with lesser expression of CYP17A mRNA in H295R cells. In zebrafish, significant up-regulation of vtg1 was observed in males exposed to PFDA, whereas down-regulation was observed in females exposed to PFTrDA. In male zebrafish, concentrations of 17β-estradiol (E2) were significantly increased at 0.01 mg L(-1) PFTrDA. Significant increases in ratios of E2/T and E2/11-ketotestosterone (11-KT) were observed in male zebrafish after exposure to PFDA or PFTrDA, indicating estrogenic potentials of these compounds. The results of this study showed that long-term exposure to PFDA or PFTrDA could modulate sex steroid hormone production and related gene transcription of the HPG axis in a sex-dependent manner. Consequences of endocrine disruptions in reproduction performances of the fish warrant further investigation.
Keywords
Hypothalamic-pituitary-gonad axis; Perfluoroalkyl acids; Sex steroid hormone; Steroidogenesis
Tags
PFAS
•
Additional PFAS (formerly XAgency)
Literature Search November 2019
Other Sources
TEDX
Screened Studies
Excluded
Exclude (TIAB)
•
Expanded PFAS SEM (formerly PFAS 430)
Litsearch: September 2019
Other Sources
PFAS TOX Database
Screened Studies
Excluded
Exclude (TIAB)
•
^Per- and Polyfluoroalkyl Substances (PFAS)
PFDA (335-76-2)
Literature Search
Pubmed
WOS
•
PFAS 150
Literature Search Update December 2020
PubMed
WOS
Literature Search August 2019
PubMed
Web of Science
Other sources
PFAS TOX Database
Screened Studies
Supplemental
Perfluorinated compounds
Perfluorodecanoic acid
Perfluorooctanoic acid
Perfluorotridecanoic acid
•
PFAS Universe
Data Source
Web of Science
Pubmed
Screened Studies
Excluded
Exclude (TIAB)
Perfluorodecanoate
Perfluorodecanoic acid
Perfluorotridecanoate
Perfluorotridecanoic acid
Perfluorooctanoic acid
•
PFBA
Protocol References
•
PFDA
Literature Search
Pubmed
WOS
Other
Published PFAS SEMs
Scopus: April 2021
Screening Results
In vivo animal studies
Repro tox
In vitro/ex vivo/in silico
Endocrine disruption
Title and Abstract Screening
Full Text Screening
Tagged as Supplemental
Mechanistic or MOA
June 2022 Pelch Database
Literature Searches (through April 2023 update and post-public comment/peer review)
Title & Abstract Screening
Full Text Screening
Tagged as Supplemental
In vitro and in silico models
Other
•
PFNA
OW - HHRAB
•
PFOA (335-67-1) and PFOS (1763-23-1)
Literature Search Update (2013-2019)
WOS
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity